Waverley Pharma (5GZ) Financial Statements
Waverley Pharma Financial Overview
Waverley Pharma's market cap is currently $345.98K. The company's EPS TTM is ―; its P/E ratio is -1.18; Waverley Pharma has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ― | ― | ― | ― | ― |
| Gross Profit | $ 79.80K | $ 581.78K | $ 222.67K | $ 181.71K | $ 48.94K |
| Operating Income | $ -2.23M | $ -638.16K | $ -786.83K | $ -709.60K | $ -1.41M |
| EBITDA | $ -1.72M | $ -435.33K | $ -726.25K | ― | ― |
| Net Income | $ -2.22M | $ -664.08K | $ -796.51K | $ -705.76K | $ -1.21M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ― | ― | ― | ― | ― |
| Total Assets | $ 952.29K | $ 2.69M | $ 3.68M | $ 3.49M | $ 4.39M |
| Total Debt | $ 1.60M | $ 701.73K | $ 262.36K | $ 40.00K | $ 0.00 |
| Net Debt | $ 1.55M | $ 567.93K | $ 104.24K | $ -670.49K | $ -1.48M |
| Total Liabilities | $ 2.09M | $ 1.60M | $ 1.89M | $ 1.45M | $ 1.55M |
| Stockholders' Equity | ― | ― | ― | ― | ― |
| Cash Flow | |||||
| Free Cash Flow | $ -1.02M | $ -237.06K | $ -798.78K | $ -361.70K | $ -1.41M |
| Operating Cash Flow | ― | ― | ― | ― | ― |
| Investing Cash Flow | ― | ― | ― | ― | ― |
| Financing Cash Flow | ― | ― | ― | ― | ― |
Currency in USD
